The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of preclinical models of human BT474 and MDA-MB-361 breast cancer that endogenously overexpress HER2 and that respond to trastuzumab.
Giulio Francia
No relevant relationships to disclose
Cynthia Rodriguez
No relevant relationships to disclose
Ping Xu
No relevant relationships to disclose
Shan Man
No relevant relationships to disclose
William Cruz-Munoz
No relevant relationships to disclose
Guido Bocci
No relevant relationships to disclose
Robert S Kerbel
No relevant relationships to disclose